The Indian Academy of Paediatrics (IAP)’s reforms: transformative or cosmetic? #medicalethics


Rema Nagarajan
25 February 2013, 08:14 PM IST, TNN

The Indian Academy of Paediatrics (IAP)’s has dismantled its Committee on Immunisation which recommends vaccines to be included in the annual immunization schedule. It is being reconstituted as IAP Advisory Committee on Vaccines and Immunisation Practices. (ACVIP).

The IAPCOI, which was almost entirely funded by vaccine manufacturers, was under a cloud following criticism about issues of conflict of interest.

In IAP’s new committee on immunization members have to abide by a very strict code of conduct and also have to sign a pretty exhaustive declaration of conflict of interest stating whether they, their employer or their immediate family members have received any money or travel grant or favour from a commercial business, industry association or research association or other enterprises with an interest related to the subject of the meeting or work. The declaration also includes statements about research support including grants, collaborations, sponsorships and other funding the person or his department or research unit might have received. It also includes non-monetary support for research such as equipment, research assistants, facilities, paid travel to meetings, investments such  as stocks, bonds, securities, in a commercial and so on. Plus, the members have to have undergone some training in the field of immunization and vaccines.

The brand name Rotarix is prominently displayed inside the hall of the PEDICON conference held last month, though IAP claims it does not promote brands

The brands Synflorix and Rotarix of GSK, a major sponsor of the conference displayed prominently all over the conference venue

Doctors thronging the stalls put up by various pharma companies especially vaccine manufacturers

Secretary general of IAP Dr Sailesh Gupta pointed out that all doctors’ associations take money, whether it is gynaecology association or the cardiology association of India, as they cannot conduct training without pharma support.

“Why only pharma? There should be concern about us taking funding from WHO or the UNICEF. Even they have an agenda. For example, UNICEF also promotes food products for children. So, even with these international agencies they will want to promote a particular food product they are using in say Africa. So, we need to be careful with them also,” said Dr Gupta. He added that there were very few organisations which were doing something about conflict of interest like the IAP.

Dr Gupta said that Medical Council of India (MCI) was not responsive to doctors’ concerns. “MCI never responds to any letter we send. Sometime back we were organising two conferences which were being funded by pharma companies. We wrote to the MCI seeking clarification regarding this. We got no response from them. Finally, we hired a lawyer specialised in MCI regulations who assured us that there was nothing amiss in conducting the conference. If MCI clarifies that organisations cannot take funds at all from pharma we will abide by that.”

He further explains: “We understand that the public has concerns about conflict of interest in us taking funding from pharma. But when we make recommendations we give an entire armament of medication for a condition and not by brand name. We ensure that pharma does not advertise inside the area where the programme is taking place even when a company is funding a session or workshop or training. We only use generic names and the only credit is to say that the programme is supported by so and so company. We are very careful about conflict of interest.”

While it is true that IAP is making efforts to address conflict of interest in its immunisation committee, it is not entirely true that IAP does not promote brands or that they do not allow advertising inside where programmes take place. A few photos from IAP’s annual conference Pedicon held just last month, show that industry particularly vaccine industry was visible everywhere and even during sessions their advertisements were being projected. Members were also being given gifts by companies at their stalls.

Is this a case of more things change, the more they remain the same? Or, is there a genuine effort to change illegal funding practices and address conflict of interest issues?

#India -Pharma firms ply doctors with gifts #medicalethics


Published: Thursday, Dec 27, 2012, 5:30 IST
By Sandeep Pai | Place: Mumbai | Agency: DNA

Even as the prime minister Manmohan Singh-led National Development Council meets on Thursday to discuss a law to curb unethical practices adopted by pharmaceutical companies to persuade doctors to promote their products, a four-month investigation by DNA has shown that the ‘pay-for-prescription’ practice flourishes.

While doctors admit that there is a grave danger of drugs being overused when pharmaceutical companies woo doctors and stockists with various sops for promoting their drugs, even the parliamentary standing committee on health and family welfare in a report dated May 8, 2012 says there is no let-up in this “evil practice”. It says, “… pharma companies continue to sponsor foreign trips of many doctors and shower them with high value gifts like air conditioners, cars, music systems, gold chains etc… to obliging prescribers who then prescribe costlier drugs as quid pro quo. Ultimately all these expenses get added up to the cost of drugs.” What’s more, the pharma firm-doctor nexus is not limited to innocuous over-the-counter drugs, a DNA investigation has found.

Take the example of US Vitamin (USV) Ltd, a major player in the oral antibiotics market. In August 2011, its product manager wrote to company representatives appreciating their efforts in making its product, Drego-D, the Number 1 prescribed brand in the preceding two months. The letter went on to say they should also push another drug, Drego, similarly, given the huge opportunity it presents. All doctors except paediatricians have the potential to prescribe Drego, the letter urged. Drego and Drego-D are both Schedule H drugs, to be sold only on the prescription of a registered medical practitioner.

The letter goes on to detail the promotional activities for the Drego group of drugs, including “on demand campaign” every month specifically for general practitioners, ENT specialists, orthopaedics, gynaecologists and more. l Turn to p9

The “engagement” and “development activity” for these doctors included investment of Rs65,000/ year or Rs80,000 per year on one or two selected doctors for a single drug, the letter revealed.

“…with such a line of promotion we are sure that you all will very easily achieve a minimum per member per month (PMPM) of 250 strips of Drego & 350 strips of Drego-D,” the letter said, going on to insist that representatives should, during their field work, ensure that doctors give Drego prescriptions “on priority”. The letter posted a target a business worth Rs14 crore for a single drug in a single year.

The company’s brochure also says doctors stood to win a smartphone or LCD television once they enter the “MPower Club” for a certain number of prescriptions of Zylera, a drug for nasal problems or asthma-like symptoms, also a Schedule H drug.
Franco India, expected to have a turnover of Rs2.1 billion this year, offers a variety of gifts to doctors, including a hamper of basmati rice, handmade orange soap, an all-in-one mobile phone charger and other stationery items.

Svizera Healthcare, a division of Maneesh Pharmaceuticals Limited, issued a brochure called Club Inspira 2010-2011, which invites doctors to become members by prescribing products worth Rs50,000 between May and August 2010. The prescriptions would have to be for Si-Fixim, Si-Fixim XL, Si-Fixim CV, FlanZen, FlanZen D/DP and others.

These are all highly sensitive drugs. Si-Fixim is generally used for the treatment of infections caused by susceptible bacteria. Doctors prescribe the medicine to patients suffering from upper respiratory tract infections, such as pharyngitis, sinusitis, tonsillitis and lower respiratory tract infections like acute bronchitis and acute exacerbation of chronic bronchitis etc. FlanZen is prescribed for reducing inflammation and edema occurring due to rheumatic disorders, surgeries, breast engorgements, pregnancy-related thrombophlebitis as well as fibrocystic breast diseases. It causes hypersensitivity reactions including rashes, abdominal discomfort and nausea if not taken properly.
Those entering the ‘club’ would be eligible for a gift, with their options ranging from a microwave oven, digital camera, a gold coin, etc.

While doctors get incentives for prescriptive drugs, incentives are offered to stockists for non-prescriptive drugs too. Though some may debate that there is nothing wrong in offering incentives to the stockists, but others believe it does make the stockist unethically push for product in order to win the gifts. While doctors get incentives for prescriptive drugs, incentives are offered to stockists for non-prescriptive drugs too.

A Gelusil festival extravaganza was announced by Pfizer to strengthen the product’s position as the Number 1 antacid in its category. Distributors were offered slab-wise gifts for achieving targets and also a chance to participate in a lucky draw. A similar offer had been launched last year for Becosules, the vitamin supplement. On offer was a chance to win diamond pendants, gold chains, travel bags, LCD televisions, home theatres, and wrist-watches.

While most pharma companies DNA approached refused to respond to queries on ethical practices while promoting drugs, Pfizer spokesperson Shyam Kumar said the company takes compliance with norms very seriously. “In fact, over the past several years, Pfizer has taken very significant steps to strengthen our internal controls and pioneer new procedures in the area of compliance. Corporate integrity is an absolute priority for Pfizer, and we will continue to take appropriate actions to strengthen public trust in our company.”

Dr Kailash Sharma, member, board of governors, Medical Council of India, and director, academics, Tata Memorial hospital, said, \”MCI has already given strict guidelines but the practice of accepting gifts is so prevalent, it becomes difficult to monitor. Doctors must restrain themselves from accepting gifts or foreign trips from pharma companies. There is a need to bring in penal provisions for pharma companies, which offer gifts to doctors. There is also a need to audit the accounts of pharma companies to know how much they are spending on publicity.”

 

#India #Rajasthan -Cheating #tribal patients under the grab of free treatment #mustshare



A compplaint lettre to Medical Council of India

The Chairman,
Medical Council of India,
New Delhi

Dear Sir:

Please find attach a pamphlet circulated by the NIMS Medical College and Hospital
(NIMS University), Shobha Nagar, JaipurDelhi Highway, Jaipur in villages
inhabited by tribal community of Pratapgarh district of Rajasthan.

A team (perhaps not of the doctors) from this college hospital held a camp on 21st October 2012
at village Devgarh of Pratapgarh block and after initial screening asked about 80
patients to come with them to NIMS Medical College Hospital, Jaipur where they
would be provided free treatment as written in the pamphlet. All these patients
were provided free transport in two buses. After reaching at NIMS Hospital, they
were admitted and asked to sleep on beds in wards.

According to the patients, doors of the hospital were locked so that they can not escape. Nobody was given

any treatment and after two days they were again put on two buses and transported
back to village Devgarh in Pratapgarh Dt. In those two days, all these patients
received food only once and tea, a couple of times. One patient said that though
his complaint was of repeated bouts of beathlessness, but a cast with weight was
put on one of his lower limbs. While they were on beds, some people peeked into
the wards but did not come near anybody.

None of the person from the hospital explained to these poor patients from tribal community the reason for not
providing treatment. The only reason, there could be that they did not have money
and they did not fall in first 500 patients who were to be given free treatment as
mentioned in the pamphlet.

From this incident, it looks like that these patients were taken to the NIMS 
Hospital to demonstrate bed occupancy for hospital to seek some kind of 
recognition. Most patients who were taken to the NIMS hospital have given 
notorized affidavits but the local administration is in no mood to do anything. 

It is a serious matter and MCI should look into it immediately.

Thanking you.

On behalf of the duped patients
Ram Prasad meena Devgarh
Naru Meena Sovani
Kanna Meena Devgarh
Jetu Ram, Samli Pathar

Prayas, Dr narendra Gupta
8, Vijay Colony, Near Railway Station,
Chittorgarh 312 001
India
Tel : +91.1472.243788
Fax : +91.1472.250044
Cell:+91.9414110328

 

Delhi High Court tells MCI to Fix rural health care course syllabus in six weeks #goodnews


 

English: National Rural Health Mission of India

English: National Rural Health Mission of India (Photo credit: Wikipedia)

 

 

R. RAMACHANDRAN

 

 

In High Court, Health Ministry puts the blame on Council for delay

The Delhi High Court has given the Medical Council of India (MCI) six weeks to finalise the curriculum for the new 3-1/2 year course, ‘Bachelor of Rural Health Care (BRHC)’. The course was proposed by the Health Ministry to meet the acute shortage of (MBBS) qualified doctors in rural areas due to which rural population was being deprived of basic, primary health care.

The court issued the order on Thursday while hearing a contempt case filed by public health specialist Meenakshi Gautham. In her plea filed on February 27, she sought contempt proceedings against the Union Health Secretary and the MCI Chairperson for not having complied with the court’s November 10, 2010 order, wherein they had been asked to initiate measures to introduce the BRHC course by March 2011.

The court had served contempt notices on the Health Secretary and the MCI and had given four weeks’ time to file their responses (see The Hindu, February 28). The contemnors had filed their affidavits in March/April and Thursday’s hearing was following their submissions.

The November 2010 order was issued following several hearings on a 2009 writ petition by Ms. Gautham and the Garhwal Community and Development Society (GCDS). The plea sought speedy introduction of the short-term course for rural health care as per the resolution of the 9th Conference of the Central Council of Health and Family Welfare in November 2007 and the recommendation of the 2007 Task Force on Medical Education Reforms for National Rural Health Mission. The order had directed the MCI to finalise the syllabus by January 2011 and the Ministry to begin the course by March 2011. Their failure to comply with the order had prompted Ms. Gautham to file the contempt petition.

DRAFT CURRICULUM READY

In its affidavit, the Ministry has stated that it was ready with a draft curriculum in October 2010 itself and this had been sent to the MCI on October 28, 2010, for its comments and final approval. But the MCI has not been able to give it a final shape even now.

Prashant Bhushan, counsel for the petitioner, said the MCI had stated in its affidavit that it would finalise the course by April 2012 but it was yet to do so even four months after that. In fact, counsel for the Centre also stated that the Ministry was still waiting for the MCI to finalise the syllabus.

REASON FOR DELAY

At Thursday’s hearing, the MCI said the delay was due to the matter being considered by yet another committee of the Council. The Bench, led by Justice Rajiv Shakdher, rejected this argument and ordered the MCI to finalise the curriculum within six weeks, failing which the MCI Secretary should be personally present. The next hearing is slated for October 18.

 

Doctors’ freebies to be Taxed :-) #Goodnews


 

C Unnikrishnan, TNN Aug 7, 2012, 03.56AM IST

MUMBAI: The income-tax (I-T) department will tax the amount pharmaceutical and allied health sector industries spend on freebies for medical practitioners and their professional associations. Those who accept the freebies will also be taxed.

The decision follows an amendment to Medical Council of India regulations banning doctors and their associations from accepting freebies. The freebies include money, travel facilities and hospitality extended by pharma firms and makers of medical devices and ‘nutraceuticals’.

The Central Board of Direct Taxes August 1 circular says the department has come across such instances and a senior pharma company official admitted companies do it to advance sales. He said a company was planning to take around 80 doctors from across the country on a full-expenses paid foreign trip for a ‘seminar’.

The I-T department grants an exemption to money spent on business promotion. It accepts firms’ claims and allows deduction. An official said, “Pharma firms cannot claim the benefit as regulations prohibit it. If we can prove the company extended freebies to doctors, they have to pay taxes. Those who receive freebies will also have to pay a tax on the gift’s value or money spent on it. If a doctor gets a fridge, its market value will be treated as income.”

Chandra Mohan Gulati, a drug regulatory expert, said it was a great first step but “let it not be the last”. He felt doctors should be told to mention details of their ‘gifts’. In 2009, MCI had set guidelines for doctors vis-a-vis pharmaceutical companies.

Ranga Iyer, who used to head Wyeth and the OPPI (Organization of Pharmaceutical Producers of India), said, “We must look at the IT Act changes in isolation. The need is for ethical marketing practices for pharmaceutical firms and we support any such move.”

Dr Arun Bal of the Association for Consumers’ Action on Safety & Health an NGO that works for patients’ rights, said, “This follows attempts by MCI and the government to bring about self-regulation among doctors and the industry.”

(With inputs from Malathy Iyer)

 

Court Battle- Denial of admission to MBBS course in AFMC


 

girl student from the Capital has moved the Delhi High Court challenging denial of admission to MBBS course by Pune’s Armed Forces Medical College(AFMC) to her on medical grounds.

On the plea by Vidushi Gupta for the court’s directions to the Centre and the AFMC for consideration of her candidature for admission, Justice G S Sistani issued notices to the medicalcollege, the Directorate General Health Services (DGHS) and the Medical Council of India (MCI). The court asked them to file their replies by August 8 and also directed the college to keep a seat vaccant for her till disposal of the matter.

Having regard to the fact that petitioner is otherwise eligible for the seat and the respondent, having granted provisional admission to her, will not fill up till the next date of hearing the one last seat, which is stated to be lying vacant/available as of today,” said Justice Sistani. Gupta, who claimed to have qualified in the merit list for admission against the vacant seats for the academic year 2012-13, was disqualified by the college on the ground of medical unfitness as a mass was found in her ovary during medical examination.

Her counsel Ashok Aggarwal submitted before the court that the act of college is illegal, unjustified, arbitrary, discriminatory, punitive, unconstitutional and violative of the fundamental rights guaranteed in the Indian Constitution. The lawyer said the prospectus for the MBBS Entrance Examination, 2012 has failed to mention ‘medical unfitness” as a ground for disqualification.

In her petition, Gupta said the mass which is inactive could be removed by a minor surgery and her father’s request to college to provide 2 weeks’ time to remove the mass was also arbitrarily denied. “The mass in the left ovary is merely a dormant minor cyst which would not affect the healthy life of the petitioner in any manner whatsoever and therefore, the college was not justified in rejecting the candidature of the petitioner,” her lawyer argued. The court slated the matter for next hearing on August 8.

 

‘Sponsored’ doctors under scanner’ #Goodnews :-)


 

English: Shivraj Singh Chauhan, Chief Minister...

English: Shivraj Singh Chauhan, Chief Minister of Madhya Pradesh, India. Français : Shivraj Singh Chauhan, chef de l’exécutif (Chief Minister) du Madhya Pradesh, Inde. (Photo credit: Wikipedia)

 

 

By Express News Service – NEW DELHI

11th July 2012 10:18 AM

Eleven doctors from Madhya Pradesh, who allegedly went with their families to England and Scotland, are facing a probe, with the Ministry of Health and Family Welfare suspecting that a pharmaceutical company could have sponsored their trip.

Speaking to Express, Medical Council of India (MCI) Secretary, Dr Sanjay

Shrivastava, said he is yet to receive a formal order from the Health Ministry for a probe against the doctors.

“Our ethics committee, which has eminent members on the board, will examine the matter after receiving the complaint and only after getting the report we will decide the next course of action,” Shrivastava said.

However, the doctors who figured in the list sent to the PMO denied taking a sponsored trip and said the group of doctors paid for the entire travel. One of the doctors, Srikant Rege of Indore told Express that he never accepted any free tickets from any drug  company and that the allegation was a farce. Another medical practitioner from Jabalpur, Dr Harsh Saxena, said somebody with ulterior motives had complained to Member of Parliament Dr Jyoti Mirdha about the group travel and there seemed to be some misunderstanding as it was a self-financed tour. He also refuted the genuineness of evidence submitted to the Prime Minister’s Office by the Mirdha.

MP Jyoti Mirdha, along with her letter, had enclosed the ticket and PNR numbers, as well as the itinerary prepared by drug manufacturing company for the travel to England and Scotland.

“As I’m writing this letter a total of 11 doctors along with their families are holidaying in England and Scotland on a trip financed by Intas Pharmaceuticals Ltd. Details including names of passengers along with their addresses, ticket numbers, hotels and itinerary are attached for your perusal. Needless to say, acceptance of such trips is in violation of MCI rules,” Mirdha’s communiqué to PM stated.

She has also raised the issue of dichotomy in rules set up to govern the sponsorship issues. “While the MCI rules bar doctors from accepting gifts, tickets, hospitality from healthcare industry, there are no corresponding obligations on the part of the drug industry not to offer such freebies and face penal action in case of violations,” the letter dated June 1, 2012, said.

After some multinational companies were fined by regulating authorities for inducing doctors through unethical means, the MCI notified a mandatory code of ethics to be followed by all medical practitioners. The gazette notification dated December 10, 2009, prohibits the acceptance of gifts, hospitality, travel grants, funds and endorsement of commercial products by doctors.

CHECK THE HOLIDAY TICKET BELOW

Intas.Doctors on holiday

 

 

 

CBI closes assets case against ex-MCI chief #WTFnews


It is very unfortunate that a most corrupt person like Ketan Desai who has amassed wealth illegally is escaping from the CBI net.

 

Rahul Tripathi : New Delhi, Sat Jul 21 2012, New Indian Express

The CBI on Friday closed the disproportionate assets case against former Medical Council of India (MCI) chairman Ketan Desai and his family, saying it did not have enough evidence to prosecute them.

This is the second high-profile case the CBI has closed in recent days, the first one being the disproportionate assets case against former Dental Council of India chief Anil Kohli.

The CBI raided Desai in April 2010 and allegedly caught him taking a Rs 2-crore bribe to grant recognition to a private medical college in Punjab. Desai’s arrest, along with that of J P Singh and Kanwaljit Singh of the medical college, and the subsequent probe highlighted deep-rooted corruption in MCI. The CBI received as many as 160 complaints of alleged violations by medical colleges that were overlooked by MCI.

The CBI then probed about two dozen colleges across India and chargesheeted former health minister Anbumani Ramadoss for granting illegal favours to a college in Indore.

In its closure report, filed in a Delhi court, the CBI claimed there was “insufficient evidence” to prosecute Desai, his wife and mother as it had not been able to link his assets to unknown sources of income.

The CBI had booked Desai after allegedly finding “illegal assets” worth Rs 24 crore during raids at his properties in Delhi and Ahmedabad.

The agency claimed Desai and his family had Rs 1.8 crore in bank deposits and owned several properties in Mumbai and Gujarat, five vehicles and gold and diamonds worth Rs 38 lakh.

The CBI then summoned Desai to explain the sources of income and assets owned by him and his family. But after a two-year-long probe, the agency concluded that “the allegations could not be substantiated”

Doctor, Heal Thyself ! # Satyamevjayate #Aamir khan


 

Doctors asks Aamir Khan to apologise for his recent show on Satyamev Jayate

 

Rediff.com, Last updated on: June 06, 2012

The latest episode of Aamir Khan‘s [ Images ] television showSatyamev Jayate probed into malpractices that some doctors follow, looking at the way they dole out wrong treatments for monetary gains. It has understandably not gone down too well with the medical fraternity.

Dr Sanjay Nagral — a consultant surgeon, department of surgical gastroenterology , Jaslok Hospital and Research Centre, Mumbai [Images ] — explains what exactly has hurt the doctors. 

Satyameva Jayate‘s recent episode on healthcare in IndiaImages ] has created quite a stir within my fraternity. What began as benign posts on social media and closed door conversations has snowballed into a movement against what is being described as a ‘diatribe’ by Aamir Khan against the medical profession.

In an additional bizarre twist, the Indian Medical Association, the apex body of medical professionals in the country, is asking Aamir to ‘apologise’ and, in what can only be termed as an acute case of silliness, has called for ‘boycotting’ him.

The issues raised in the show, and the profession’s response to them, have important lessons. Lest they get lost in the din and drama, here is a contrarian view for the record.

What is it exactly in that episode that has hurt my colleagues?

From my reading of the various statements, it seems there are some common themes that many are upset about.

First, the show ‘exaggerated’ the extent of unethical practice in the profession. Second, it showed only the ‘bad’ side of the profession, not the ‘good’. Third, it was factually incorrect at times.

There were those who wanted to know why doctors are being targeted when the entire society is corrupt.

Finally, the one below the belt: Who is Aamir Khan to pontificate about service to the poor when he charges crores of rupees for the show?

The last one, though probably the most superfluous, is the most emotive of all.

Is it really a revelation that ‘stars’ like Aamir charge such amounts for television serials? If Aamir declares he has not charged for the show, will it in any way alter the response to the show?

Post your comments on Satyamev Jayate here.

Now, we come to the more substantive issues.

What was one of the unethical practices that the show highlighted and ‘exaggerated’? The episode talked about the practice of ‘cuts’ and ‘commissions’ that are offered by doctors, labs and hospitals for referral of patients. These are cash transactions; they are not revealed in official documents and are arbitrary in amount.

Although there is no documentation of the extent of this practice (Not surprising! How many would admit to it?), having had a ringside view in a large metropolis for many years, I would suggest it involves a large majority of referrals.

We can quibble over the precise extent, but that would just serve to obfuscate the issue at hand.

Hasn’t such ‘fee splitting’ become so commonplace and institutionalised that, as a young doctor, if you don’t participate in it, you are effectively ostracised? Isn’t this activity non-transparent and doesn’t it increase the cost of health care and affect quality? Has any medical association ever tried to build internal resistance or opposition to such a patently corrupt practice?

The show talked about the shocking state of the Medical Council of India and how its president, Dr Ketan Desai, was arrested by the CBI in 2010 on charges of corruption. He was thereafter removed from the post of MCI president by the government and is now cooling his heels in Tihar jail.

Desai amassed crores (one estimate pegs the amount of money recovered from the raid on his home at Rs 1800 crore (Rs 18,000 million)) from the lucrative business of recognition of medical colleges.

The episode also showed how Desai, who had been indicted by the courts and temporarily sacked in 2002, staged a return. What the episode did not mention is that the same individual was also the national president of the Indian Medical Association.

Thus, a convicted individual not just survived but actually thrived for an entire decade at the highest levels in the Indian medical establishment both as the president of the Medical Council as well as the IMA. Isn’t this a reflection of the permissiveness and ambivalence medical professionals have developed towards corruption in their own representative bodies?

The current president Dr K K Talwar, who appeared on the show, had no credible answer when asked why not a single doctor in India has had his licence cancelled when the General Medical Council of the UK figures showed substantive numbers every year.

One of the ‘errors’ repeatedly pointed out by those outraged by the show is the numbers that were quoted about private and public medical colleges in India. One wonders, though, what is more important — the precise number or the fact that India can be counted among the countries that have the highest number of private medical colleges in the world? Isn’t the crass commerce of medical education in these colleges, where seats are sold at high prices, the real issue?

Isn’t it true that private medical college empires have grown because they have managed to hire and retain medical teachers, set up arrangements with hospitals to provide ‘clinical material’ in the form of patients and get recognition for postgraduate courses from inspection teams consisting largely of doctors?

Of course, there is a large industry supported by politicians at work here but the collusion of the profession is substantial.

Did the episode show examples of ‘good’ doctors and the positive side of things?

To be fair, the show did profile alternative models quite extensively. The issue of generic drugs and the work of Dr Samit Sharma in Rajasthan [ Images ] were highlighted in some detail.

That they predictably chose media favourite Dr Devi Shetty, when they could have profiled any of the hundreds of brave, committed doctors who have chosen to work under harsh  conditions in rural India to come up with alternative models of people-centric health care, is a pity. But some of this is inherent to the medium and its compulsions.

And, finally, a very old complaint — why should doctors be ‘targeted’ when the entire society is commercial and corrupt?

It is obvious that, unlike other professions, health care has a huge social dimension and hence will inevitably be scrutinised more intensely. But it is exactly this aspect that also gives doctors more visibility (don’t many of our colleagues enjoy a lot of media publicity on a regular basis?).

Historically medicine has a social contract which allows it a unique form of self-regulation in the form of medical councils, a front on which we have failed miserably. So whether it is the killing of the female foetus or the sale of kidneys, the state has had to step in with new laws because self-regulation failed.

The principle of market economics have been rejected by most societies, including western nations, as inappropriate to health care. In a strange paradox, India has one of the most privatised of health care systems.

Now, before my colleagues say that this is a result of state policy, which it essentially is, we have to admit India’s medical profession is a willing and enthusiastic participant in this process. Witness in the current boom of market medicine a new entrepreneurial spirit that is sweeping the profession. But the same market medicine, which uses media and television to sell its wares, is disturbed when the medium turns around and asks disturbing questions.

Was the show free of blemishes? Of course not.

There were occasional moments, like when the rather improbable allegation of a ‘liver transplant’ being advised for gastroenteritis was made by a member of the audience. Or when a family alleged that they did not know that a pancreas would be transplanted with the kidney in a large private hospital in Bengaluru [ Images ]. But these aberrations should not distract from the big issues that the show managed to raise.

Rampant commercialisation of the practice and of medical education, hard selling by pharmaceuticals, the high cost of drugs and the shocking price differences for the same drug from different brands are all highly disturbing parts of our healthcare policy.

That a popular film star with a huge audience articulated on prime time television what health activists have been saying for years is perhaps what has disturbed some in my fraternity.

Organisations like the IMA should actually seize the moment and ask Aamir to commit to a sustained public campaign on universal health coverage and the right to health. That would also test Aamir on a charge that has been made about him; that he raises social concerns transiently to stimulate interest in an ongoing release.

As for the boycott call, I would suggest that Aamir doesn’t really need to worry on that count. He has to just sneeze or cough and there will be a bevy of doctors running to attend on him.

After all, being a film star’s physician counts a lot in a doctor’s professional trajectory in India.

Immediate Release- Illegal Clinical Trials and Death Continue …


SWASTHYA ADHIKAR MANCH

6, BIJASAN ROAD, OPPOSITE MAHAVIR BAGH, INDORE, MADHYA PRADESH-452005.

Press Note

New Delhi, 26th March 2012 : The Writ Petition filed by Swasthya Adhikar Manch came up for hearing today before a bench consisting of Justice R.M. Lodha and Justice H. L. Gokhale. The Senior Counsel appearing for the Union of India sought time to file counter affidavit. The Medical Council of India as well as State of Madhya Pradesh also asked for time and were granted six weeks. Thereafter, petitioner Swasthya Adhikar Manch has been granted time to file Rejoinder Affidavit.The counsel for Swasthya Adhikar Manch, Mr Sanjay Parikh, pointed out that it has been acknowledged by Minister of Health and Family Affairs, that illegal trials have been conducted and some of them are even without approval of the DCGI. He also mentioned that no Placebo Trials should be conducted in the country. The Hon’ble Judges remarked that the situation is serious and deaths are taking place. On the application for impleadment filed on behalf of Contract Research Organizations, the Supreme Court sought information about their legal status for operating in the Country. The Counsel for the petitioner pointed out that these Contract Research Organizations outsource and offshore the clinical trials on behalf of the multinational drug companies and ensure one window solutions for getting approval of the DCGI.

Meanwhile, the issue, being of national importance has been raised in MP Vidhan Sabha and the Rajya SabhaIn response to a question in the Madhya Pradesh Vidhan Sabha, it was stated that out of 81 patients who had suffered serious adverse effects, 33 persons have died. A list of names and addresses was provided which indicate death of 33 persons including children. No action has been taken by State of Madhya Pradesh inspite of such shocking state of affairs.

The Union Minister of Health and Family Welfare in a recent answer on March 13th to a question in Rajya Sabha pointed out that during the last 3 years 2009, 2010 and 2011 a total of 1229 trials were conducted in which 1743 deaths occurred in last 3 years and 2163 deaths in last 5 years as per data collected from Rajya Sabha and RTI documents. It was also mentioned that only in 22 cases of death in 2010 that the compensation has been paid by sponsors / clinical research organizations. The Petitioners – Swasthya Adhikar Manch are extremely concerned at this situation and further increasing number of deaths. We urge that even during pendency of the Writ Petition, the Union Ministry of Health and Family Welfare should take steps to stop the illegal clinical trials.

Amulya Nidhi, Chinmay Mishra

(9425311547), (9893278855)

(amulyabhai@gmail.com) (chinmay.saroj@gmail.com)

Follow

Get every new post delivered to your Inbox.

Join 6,855 other followers

%d bloggers like this: